@OptionWell Their leadership team bought a ton of stock right out of the gate as well! I opened a position today.
https://t.co/IdTmk3sbqW
https://t.co/97zg3N0v95
Just came across $XZO, a brand new public company (IPO Nov 5) offering a full insurance-as-a-service platform for P&C carriers and agents.
What stands out: on basically Day 1 of trading, the CEO bought ~$1M, plus directors and execs scooped up hundreds of thousands more. A unified front of insider buys from senior leadership is a strong signal, but I’m not sure why they all hit it on Day 1. Haven’t really seen this before. Will continue to monitor.
@_The_Prophet__ Enlightened subscriber since August 1st. The Signal can no longer be ignored. 📡
Information is reaching escape velocity, it's only been accelerated in the age of unlimited compute power.
If you're not in tune, you are living in the past.
@KyleAdamsStocks Keep the coming! Would love to hear your "Cheap Compounders to Buy" ideas for right now, seeing some very good companies trade at 52 week lows.
@doomerzoomer $ASAN. Sticky revenue, tons of customers, new veteran CEO, stock float shrinking and their AI assisted project management product is growing in adoption.
@realMerryMonk@mvcinvesting Strong portfolio of ophthalmic-focused products with recurring revenue. VEVYE is the fastest-growing prescription for dry eye condition, still rolling out in the US. Look up reviews for those eye drops.